CIK 0000727510 · Non-accelerated filer<br>Smaller reporting company
Viskase Holdings, Inc.
Sign in to watch- Ticker
- VISK
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 222372868
- Phone
- (630) 874-0700
- Business address
- 333 EAST BUTTERFIELD ROAD, SUITE 400, LOMBARD, IL, 60148
- Former names
- ENZON PHARMACEUTICALS, INC., ENZON PHARMACEUTICALS INC, ENZON PHARMACEUTICALS INC, ENZON PHARMACEUTICAL INC, ENZON INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2012-11-07 | HEBARD GEORGE Interim PEO and Interim COO | Grant or award · Stock Option (Right to Buy) | +73,500 | 73,500 | ||
| 2012-08-14 | LEBUHN ROBERT Director | Sale | −5,820 | $6.58 | $38K | 98,115 |
| 2012-08-10 | LEBUHN ROBERT Director | Sale | −1,933 | $6.58 | $13K | 103,935 |
| 2012-07-02 | Young Richard A Director | Grant or award | +10,669 | 30,231 | ||
| 2012-07-02 | SALISBURY ROBERT C Director | Grant or award | +10,669 | 67,707 | ||
| 2012-07-02 | LEBUHN ROBERT Director | Grant or award | +10,669 | 105,868 | ||
| 2012-07-02 | Deuel Thomas Director | Grant or award | +10,669 | 32,231 | ||
| 2012-07-02 | Mulligan Richard Director | Grant or award | +18,670 | 49,064 | ||
| 2012-07-02 | DENNER ALEXANDER J Director | Grant or award | +21,338 | 60,620 | ||
| 2012-06-20 | HEBARD GEORGE Interim PEO and Interim COO | Purchase | +5,000 | $6.88 | $34K | 18,737 |
| 2012-06-05 | Rackear Andrew D. VP and General Counsel | Sale | −1,614 | $6.81 | $11K | 56,720 |
| 2012-06-05 | Conover Charles SVP, R&D Program Management | Sale | −25,000 | $6.78 | $170K | 57,213 |
| 2012-03-28 | Daly Timothy VP, Controller and PAO | Grant or award | +8,000 | 8,000 | ||
| 2012-03-15 | Young Richard A Director | Sale | −2,000 | $6.92 | $14K | 19,562 |
| 2012-02-27 | HEBARD GEORGE Director | Grant or award | +13,737 | 13,737 | ||
| 2012-02-27 | HEBARD GEORGE Director | Grant or award · Stock Option (Right to Buy) | +10,297 | 10,297 | ||
| 2012-01-17 | Buchbinder Aby VP, Clinical Development | Grant or award | +4,000 | 58,015 | ||
| 2012-01-17 | Buchbinder Aby VP, Clinical Development | Grant or award · Employee Stock Option (Right to Buy) | +12,000 | 12,000 | ||
| 2012-01-17 | Conover Charles SVP, R&D Program Management | Grant or award | +10,000 | 82,213 | ||
| 2012-01-17 | Conover Charles SVP, R&D Program Management | Grant or award · Employee Stock Option (Right to Buy) | +25,000 | 25,000 |
Page 6 of 12 · 223 trades